TFS is a full service clinical Contract Research Organisation (CRO) which has served the Life Science Industry with a wide range of clinical trial services since 1996.
TFS offers services in Phase I, trials in Phase II–III and post-marketing surveillance trials in Phase IV. Any of the services can be contracted individually or collectively, including Clinical Pharmacology, Clinical Operations, Clinical Data Management, Biostatistics, Medical Writing, Regulatory Affairs, Drug Safety, Quality Assurance, Training and Contract Placement.
TFS Phase I Unit is located at the distinguished Karolinska University Hospital in Stockholm, Sweden. The unit is highly specialised and equipped to perform first-in-man, human tolerance, safety and proof-of-concept studies and imaging studies with Positron Emission Tomography (PET).
TFS has conducted clinical trials in 19 different therapeutic areas covering more than 150 indications. The major therapeutic areas are oncology, CNS, endocrinology, cardiology, infection, urology and vaccines.
With 450 employees and 19 offices spread throughout Europe, Asia and USA TFS can assure easy access to client and investigational sites.
TFS has offices in the following countries: Sweden (HQ), Finland, Denmark, Norway, The Baltic states, Russia, Spain, Italy, Portugal, United Kingdom, France, The Netherlands, India, Japan and USA.
For more information about TFS please click here to visit our homepage.